BIONOR IMMUNO AS

0278 OSLO

Finances

Share Ownership

Return on Equity

22,93 %

Current Ratio

0,04

Debt-to-Equity Ratio

−0,45

Key figures (NOK)	2021	2020	2019	2018
Revenue	64 000	0	419 000	0
Net Income	−2 605 000	−4 990 000	−8 519 000	−6 821 000
Total Assets	292 000	451 000	2 888 000	2 108 000
Total Equity	−11 360 000	−8 755 000	−3 764 000	−2 145 000

Income (NOK)	2021	2020	2019	2018
Revenue	64 000	0	419 000	0
Expenditure	2 655 000	4 793 000	8 826 000	6 828 000
Operating Profit	−2 590 000	−4 794 000	−8 407 000	−6 827 000
Financial Income	15 000	23 000	8 000	45 000
Financial Costs	30 000	220 000	120 000	40 000
Financial Balance	−15 000	−197 000	−112 000	5 000
Earnings Before Tax	−2 605 000	−4 990 000	−8 519 000	−6 821 000
Tax	0	0	0	0
Net Income	−2 605 000	−4 990 000	−8 519 000	−6 821 000

Balance (NOK)	2021	2020	2019	2018
Total Fixed Assets	0	0	0	0
Total Current Assets	292 000	451 000	2 888 000	2 108 000
Total Assets	292 000	451 000	2 888 000	2 108 000
Total Retained Equity	−608 928 000	−606 323 000	−601 332 000	−592 813 000
Total Equity	−11 360 000	−8 755 000	−3 764 000	−2 145 000
Total Long-Term Debt	5 059 000	5 059 000	5 059 000	0
Total Current Debt	6 593 000	4 147 000	1 593 000	4 253 000
Total Equity and Debt	292 000	451 000	2 888 000	2 108 000

Cash flow (NOK)	2021	2020	2019	2018
Sales Income	64 000	0	419 000	0
Other Income	0	0	0	0
Revenue	64 000	0	419 000	0
Cost of Goods Sold	11 000	61 000	28 000	11 000
Salary Costs	15 000	791 000	149 000	1 213 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	2 655 000	4 793 000	8 826 000	6 828 000
Operating Profit	−2 590 000	−4 794 000	−8 407 000	−6 827 000
Financial Income	15 000	23 000	8 000	45 000
Financial Costs	30 000	220 000	120 000	40 000
Financial Balance	−15 000	−197 000	−112 000	5 000
Dividends	0	0	0	0
Net Income	−2 605 000	−4 990 000	−8 519 000	−6 821 000

Balance details (NOK)	2021	2020	2019	2018
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	39 000	351 000	887 000	311 000
Total Current Assets	292 000	451 000	2 888 000	2 108 000
Total Assets	292 000	451 000	2 888 000	2 108 000
Total Equity	−11 360 000	−8 755 000	−3 764 000	−2 145 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	5 059 000	5 059 000	5 059 000	0
Creditors	265 000	640 000	481 000	197 000
Unpaid Taxes	31 000	339 000	4 000	92 000
Dividends	0	0	0	0
Other Current Debt	6 297 000	3 167 000	1 109 000	3 963 000
Total Current Debt	6 593 000	4 147 000	1 593 000	4 253 000
Total Equity and Debt	292 000	451 000	2 888 000	2 108 000

Financial indicators	2021	2020	2019	2018
Return on Equity	22,93 %	57 %	226,33 %	318 %
Debt-to-Equity Ratio	−0,45	−0,58	−1,34	−0
Operating Profit Margin	−4 046,88 %	-	−2 006,44 %	-
Current Ratio	0,04	0,11	1,81	0,5
Quick Ratio	0,04	0,11	1,81	0,5
Equity Ratio	−38,9	−19,41	−1,3	−1,02
Gross Profit Margin	82,81 %	-	93,32 %	-